Not applicableStudy completedNCT00896896What this trial is testingImmunoreactivity to Cetuximab in Cancer PatientsWho this might be right forColorectal CancerHead and Neck Cancer Vanderbilt-Ingram Cancer Center 538
Large-scale testing (Phase 3)WithdrawnNCT00041171What this trial is testingDocetaxel and St. John's Wort in Treating Patients With Solid Tumors That Cannot Be Removed By SurgeryWho this might be right forAdult Solid TumorBreast CancerHead and Neck Cancer+3 more Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT00040807What this trial is testingIrinotecan and Docetaxel in Treating Patients With Metastatic or Locally Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Eastern Cooperative Oncology Group
Not applicableStudy completedNCT02245100What this trial is testingCirculating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaSalivary Gland Squamous Cell CarcinomaStage IIIA Non-small Cell Lung Cancer+27 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 130
Not applicableStudy completedNCT00828516What this trial is testingUsing Traditional Acupuncture in the Management of Cancer Treatment Related LymphoedemaWho this might be right forBreast CancerHead and Neck CancerLymphedema East and North Hertfordshire NHS Trust 56
Testing effectiveness (Phase 2)Study completedNCT00337129What this trial is testingS0618 E7389 in Treating Patients With Metastatic or Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer National Cancer Institute (NCI) 42
Testing effectiveness (Phase 2)Study completedNCT00526149What this trial is testingBI 2536 in Treating Patients With Recurrent or Metastatic Solid TumorsWho this might be right forBreast CancerEndometrial CancerHead and Neck Cancer+3 more European Organisation for Research and Treatment of Cancer - EORTC 76
Not applicableEnded earlyNCT00891904What this trial is testingRadiation Therapy and Cetuximab in Treating Patients With Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer Roswell Park Cancer Institute 2
Very early researchEnded earlyNCT00499733What this trial is testingCyclophosphamide and Cryoablation in Treating Patients With Advanced or Metastatic Epithelial CancerWho this might be right forCancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00057850What this trial is testingBMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck CancerWho this might be right forHead and Neck Cancer National Cancer Institute (NCI) 27
Early research (Phase 1)WithdrawnNCT01332279What this trial is testingEverolimus, Erlotinib Hydrochloride, and Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer Previously Treated With Radiation TherapyWho this might be right forRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland CancerRecurrent Squamous Cell Carcinoma of the Hypopharynx+8 more Fox Chase Cancer Center
Testing effectiveness (Phase 2)Study completedNCT01256385What this trial is testingTemsirolimus With or Without Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck Cancer Who Did Not Respond to Previous TherapyWho this might be right forRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell CarcinomaRecurrent Laryngeal Verrucous Carcinoma+33 more National Cancer Institute (NCI) 86
Testing effectiveness (Phase 2)Ended earlyNCT04162873What this trial is testingCelecoxib Through Surgery and Radiation Therapy for the Treatment of Advanced Head and Neck CancerWho this might be right forClinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8Nasal Cavity and Paranasal Sinus Carcinoma+23 more University of Utah 13
Testing effectiveness (Phase 2)Study completedNCT00095628What this trial is testingSB-715992 in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forMetastatic Squamous Neck Cancer With Occult Primary Squamous Cell CarcinomaRecurrent Metastatic Squamous Neck Cancer With Occult PrimaryRecurrent Salivary Gland Cancer+19 more National Cancer Institute (NCI) 21
Early research (Phase 1)Study completedNCT01172028What this trial is testingPemetrexed Disodium and Docetaxel in Treating Patients With Advanced Solid TumorsWho this might be right forBreast CancerEsophageal CancerGastric Cancer+4 more University of Arizona 33
Early research (Phase 1)Study completedNCT00066651What this trial is testingImmunotoxin Therapy in Treating Patients With Advanced Solid TumorsWho this might be right forCervical CancerFallopian Tube CancerHead and Neck Cancer+5 more National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00030576What this trial is testingErlotinib and Cisplatin in Treating Patients With Recurrent or Metastatic Head and Neck CancerWho this might be right forHead and Neck Cancer University Health Network, Toronto 51
Early research (Phase 1)Study completedNCT01637194What this trial is testingCetuximab and Everolimus in Treating Patients With Metastatic or Recurrent Colon Cancer or Head and Neck CancerWho this might be right forRecurrent Adenoid Cystic Carcinoma of the Oral CavityRecurrent Basal Cell Carcinoma of the LipRecurrent Colon Cancer+46 more Fox Chase Cancer Center 12
Testing effectiveness (Phase 2)WithdrawnNCT00095641What this trial is testingS0225 Capecitabine in Treating Patients Who Have Undergone Surgery for Locally Recurrent or Persistent Head and Neck CancerWho this might be right forRecurrent Squamous Cell Carcinoma of the Lip and Oral CavityRecurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal CavityRecurrent Squamous Cell Carcinoma of the Hypopharynx+2 more SWOG Cancer Research Network
Not applicableStudy completedNCT00809016What this trial is testingPET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation TherapyWho this might be right forHead and Neck Cancer Centre Oscar Lambret 40